The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of knock-off medications, significantly eroding its position . While certain firms may seek to capitalize on male sexual dysfunction, the current landscape